IP Library Granted Patent US 7,220,584
Granted Patent B2
US 7,220,584 · App. 10/632,399 · Granted May 22, 2007

Method of making embryoid bodies from primate embryonic stem cells

Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,220,584
App. No.
10/632,399
Granted
May 22, 2007
Kind
B2
Abstract

Primate embryoid bodies are formed from primate ES cells. The ES cells form clumps. One then removes the clumps, as clumps, and permits incubation under non-adherent conditions. The development of embryoid bodies from primate ES cells is dependent on maintaining the aggregation of cells, as individualized cells will rapidly die.

Claims (14)

1. A method for producing differentiated human cells from human embryonic stem cells, the method comprising:

culturing human embryonic stem cells under conditions such that at least some of the cells adhere to a substrate;

removing the adhering colonies of the embryonic stem cells from the substrate in clumps;

then incubating the clumps in a container under conditions in which the clumps are essentially inhibited from attaching to the container and under conditions in which the clumps of embryonic stem cells coalesce into embryoid bodies; and

culturing the embryoid bodies to produce human differentiated cells.

2. The method of claim 1 , wherein the human differentiated cells are selected from the group consisting of neural cells, cardiac cells and hematopoietic cells.

3. The method of claim 1 , wherein the removal step is conducted in the presence of an enzyme that promotes disassociation of the clumps as clumps from the substrate.

4. The method of claim 3 , wherein the enzyme is dispase.

5. The method of claim 1 , wherein the removal step is conducted in the presence of a chelating agent.

6. The method of claim 1 , wherein the removal step comprises mechanically scraping the clumps from the substrate.

7. The method of claim 1 , wherein the removal step is conducted in the presence of trypsin, calcium and magnesium.

8. The method of claim 1 , wherein the incubation step comprises agitating the container.

9. The method of claim 1 , wherein the incubation step is conducted in a container made of plastic.

10. The method of claim 1 , wherein the incubation step is conducted in the presence of a serum-free medium.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 16, 2018
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046172/0738 →
Continuity (2)
Continuation 0951044400 · Feb 21, 2000
Related Publication 20040023376A1 · Feb 5, 2004